Pancreatic Cancer Research

ResearcherUniversity of MinnesotaActive in the last 2 years

Mizuho Sato‐Dahlman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2019-5557; OpenAlex author ID A5055832438. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. Targeting pancreatic cancer with adenoviral vectors equipped with transgenes. First author DOI 10.1158/1535-7163.mct-25-1231↗
  2. Inhibition of fatty acid binding protein suppresses pancreatic cancer progression and metastasis. Co-author DOI 10.1038/s41598-025-11271-9↗
  3. Interferon-expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model. Co-author DOI 10.1111/cas.15903↗
  4. Fatty acid binding protein 4 regulates pancreatic cancer cell proliferation via activation of nuclear factor E2-related factor 2. Co-author DOI 10.1016/j.soard.2021.12.002↗
  5. The Development of Oncolytic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer Co-author DOI 10.2174/1568009617666170222123925↗
  6. Role of Gene Therapy in Pancreatic Cancer-A Review. Co-author DOI 10.3390/cancers10040103↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masato Yamamoto · 6 shared papers, 2018–2026 · strength 1.27
  2. Shuhei Shinoda · 3 shared papers, 2022–2025 · strength 0.62
  3. Kazuho Inoko · 2 shared papers, 2023–2025 · strength 0.45
  4. Ingunn M. Stromnes · 1 shared paper, 2026 · strength 0.33
  5. Brett Roach · 1 shared paper, 2026 · strength 0.33
  6. Keith M. Wirth · 2 shared papers, 2018–2022 · strength 0.31
  7. Julia Davydova · 1 shared paper, 2023 · strength 0.19
  8. Nikita Sharma · 1 shared paper, 2023 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.